Polymeric-based nanocomposite coatings were synthesized by reinforcing epoxy matrix with titanium nanotubes (TNTs) loaded with dodecylamine (DOC). The performance of the developed nanocomposite coatings was investigated in corrosive environments to evaluate their anti-corrosion properties. The SEM/TEM, TGA, and FTIR analysis confirm the loading of the DOC into the TNTs. The UV-Vis spectroscopic analysis confirms the self-release of the inhibitor (DOC) in response to the pH change. The electrochemical impedance spectroscopic (EIS) analysis indicates that the synthesized nanocomposite coatings demonstrate superior anticorrosion properties at pH 2 as compared to pH 5. The improved anticorrosion properties of nanocomposite coatings at pH 2 can be attributed to the more effective release of the DOC from the nanocontainers. The superior performance makes polymeric nanocomposite coatings suitable for many industrial applications.
The accumulation and aggregation of α-synuclein (α-syn) is the main pathologic event in Parkinson’s disease (PD), dementia with Lewy bodies, and multiple system atrophy. α-Syn-seeded fibril formation and its induced toxicity occupy a major role in PD pathogenesis. Thus, assessing compounds that inhibit this seeding process is considered a key towards the therapeutics of synucleinopathies. Using biophysical and biochemical techniques and seeding-dependent cell viability assays, we screened a total of nine natural compounds of alkaloid origin extracted from Chinese medicinal herbs. Of these compounds, synephrine, trigonelline, cytisine, harmine, koumine, peimisine, and hupehenine exhibited in vitro inhibition of α-syn-seeded fibril formation. Furthermore, using cell viability assays, six of these compounds inhibited α-syn-seeding-dependent toxicity. These six potent inhibitors of amyloid fibril formation and toxicity caused by the seeding process represent a promising therapeutic strategy for the treatment of PD and other synucleinopathies.
Aggregated α-synuclein (αSyn) protein is a core pathological feature of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Both PD and DLB demonstrate the presence of diverse intracellular α-synuclein (αSyn) species, including C-terminally truncated αSyn (C-αSyn), although it is unknown how C-αSyn species contribute to disease progression. Using recombinant C-αSyn and PD and DLB brain lysates as seeds in the real-time quaking-induced conversion (RT-QuIC) assay, we explored how C-αSyn may be involved in disease stratification. Comparing the seeding activity of aqueous-soluble fractions to detergent-soluble fractions, and using αSyn 1-130 as substrate for the RT-QuIC assay, the temporal cortex seeds differentiated PD and DLB from healthy controls. In contrast to the temporal cortex, where PD and DLB could not be distinguished, αSyn 1-130 seeded by the detergent-soluble fractions from the PD frontal cortex demonstrated greater seeding efficiency compared to the DLB frontal cortex. Moreover, proteinase K-resistant (PKres) fragments from the RT-QuIC end products using C-αSyn 1-130 or C-αSyn 1-115 were more obvious in the frontal cortex compared to the temporal cortex. Morphological examinations of RT-QuIC end products showed differences in the size of the fibrils between C-αSyn 1-130 and C-αSyn 1-115, in agreement with the RT-QuIC results. These data show that C-αSyn species can distinguish PD from DLB and suggest diversity in αSyn species across these synucleinopathies, which could play a role in disease progression.
The assessment of blood glucose levels is necessary for the diagnosis and management of diabetes. The accurate quantification of serum or plasma glucose relies on enzymatic and nonenzymatic methods utilizing electrochemical biosensors. Current research efforts are focused on enhancing the non-invasive detection of glucose in sweat with accuracy, high sensitivity, and stability. In this work, nanostructured mesoporous carbon coupled with glucose oxidase (GOx) increased the direct electron transfer to the electrode surface. A mixed alloy of CuNi nanoparticle-coated mesoporous carbon (CuNi-MC) was synthesized using a hydrothermal process followed by annealing at 700 °C under the flow of argon gas. The prepared catalyst’s crystal structure and morphology were explored using X-ray diffraction and high-resolution transmission electron microscopy. The electrocatalytic activity of the as-prepared catalyst was investigated using cyclic voltammetry (CV) and amperometry. The findings show an excellent response time of 4 s and linear range detection from 0.005 to 0.45 mM with a high electrode sensitivity of 11.7 ± 0.061 mA mM cm−2 in a selective medium.
In this work, bimetallic PdxCoy nanoparticles supported on nitrogen-doped reduced graphene oxide catalysts were synthesized and tested for formic acid oxidation as potentially efficient and durable electrocatalysts. Graphene oxide was nitrogen doped through hydrothermal chemical reduction with urea as a nitrogen source. The PdxCoy nanoparticles were deposited on the nitrogen-doped graphene oxide support using the impregnation-reduction method with sodium borohydride as a reducing agent and sodium citrate dihydrate as a stabilizing agent. The structural features, such as phases, composition, oxidation states, and particle sizes, of the nanoparticles were characterized using X-ray diffraction, transmission electron microscopy, scanning electron microscopy–energy-dispersive X-ray spectroscopy, and X-ray photoelectron spectroscopy. The Pd nanoparticle sizes in Pd1Co1/N-rGO, Pd/N-rGO, and Pd1Co1/CNT were 3.5, 12.51, and 4.62 nm, respectively. The electrochemical performance of the catalysts was determined by CO stripping, cyclic voltammetry, and chronoamperometry. Pd1Co1/N-rGO showed the highest mass activity of 4833.12 mA–1 mg Pd, which was twice that of Pd1Co1/CNT. Moreover, Pd1Co1/N-rGO showed a steady-state current density of 700 mA–1 mg Pd after 5000 s in chronoamperometry carried out at +0.35 V. Apart from the well-known bifunctional effect of Co, nitrogen-doped graphene contributed to the performance enhancement of the Pd1Co1/N-rGO catalyst.